The IDEA-FAST Clinical Observation Study is on a roll! We are proud to announce that Stavanger University recruited last week their first patient and they are ready to start. We are looking forward to one intense year with 2000 participants and 15 clinical sites across Europe.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
